Poor economy hits AMO's 2008 outlook
This article was originally published in Clinica
Executive Summary
The weakening economy has dealt a bigger-than-expected blow to Advanced Medical Optics' US and European laser vision correction businesses, resulting in the company having to slash its revenue and profit outlook for 2008. The Santa Ana, California firm is now expecting revenue for the year to be between $1.7-1.2bn, down from the previous forecast of $1.22-1.24bn. Earnings-per-share is anticipated to sink below the $1-mark to reach between $0.70-0.80, compared with $1-1.15 as previously expected. The news sent AMO's shares plunging to an all-time low, closing at $6.83 per share on Friday (October 10).One silver lining in the cloud was the company's performance in the Japanese and Asia-Pacific markets, which the firm said was growing at double digit rates.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.